Enhanced metabolic function: Retatrutides unique activation of glucagon receptors adds to its appeal by boosting energy expenditure and metabolic rate, contributing to overall metabolic health
From this perspective, peptides such as relaxin-3 may be more relevant to behavioral subtypes of metabolic disease than to weight loss per se
Related Articles and Topics: Intermittent Fasting: Benefits from changing Gene Expression References: Alsuwailem, Omar A., et al
A new Alzheimers disease interventive strategy: GLP-1
From the 4 mg dose, reaching nearly 20% weight loss with one escalation step, to the 12 mg dose that delivered a level of weight loss long associated with bariatric surgery, retatrutide offers the potential for a patient-centric approach to obesity
GLP-1 is released in response to food intake, and has several important functions, including stimulating insulin release, suppressing glucagon release, slowing gastric emptying, and reducing appetite